Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2011

May 16, 2011

30339_dirs_2011-05-16_2070e554-ecce-4aa8-a0ac-18be2d14f9df.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2011-02-04

Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 23739.2744 Indirect

Footnotes

F1: Change in amount of securities beneficially owned is due to change of form of ownership from indrect to direct due to the distribution of vested deferred stock units credited to the participant's account under the terms of the Nonqualifed Deferred COmpensation Plan for Designated Employees. 4,517 of these deferred stock units were distributed in the form of unrestricted whole shares of stock and are now held directly by the participant and 418.8593 shares were distributed to the participant in cash.